DE3466392D1 - Imidazoquinazoline compound - Google Patents

Imidazoquinazoline compound

Info

Publication number
DE3466392D1
DE3466392D1 DE8484107130T DE3466392T DE3466392D1 DE 3466392 D1 DE3466392 D1 DE 3466392D1 DE 8484107130 T DE8484107130 T DE 8484107130T DE 3466392 T DE3466392 T DE 3466392T DE 3466392 D1 DE3466392 D1 DE 3466392D1
Authority
DE
Germany
Prior art keywords
compound
imidazoquinazoline
imidazoquinazoline compound
tetrahydroimidazo
quinazolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484107130T
Other languages
German (de)
English (en)
Inventor
Fumiyoshi Ishikawa
Shinichiro Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3466392D1 publication Critical patent/DE3466392D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Furan Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DE8484107130T 1983-06-21 1984-06-20 Imidazoquinazoline compound Expired DE3466392D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58111498A JPS604186A (ja) 1983-06-21 1983-06-21 イミダゾキナゾリン化合物

Publications (1)

Publication Number Publication Date
DE3466392D1 true DE3466392D1 (de) 1987-10-29

Family

ID=14562811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484107130T Expired DE3466392D1 (de) 1983-06-21 1984-06-20 Imidazoquinazoline compound

Country Status (19)

Country Link
US (1) US4596806A (enExample)
EP (1) EP0129258B1 (enExample)
JP (1) JPS604186A (enExample)
KR (1) KR910003153B1 (enExample)
AT (1) ATE29884T1 (enExample)
AU (1) AU558124B2 (enExample)
CA (1) CA1231946A (enExample)
DE (1) DE3466392D1 (enExample)
DK (1) DK162999C (enExample)
ES (1) ES533609A0 (enExample)
FI (1) FI77864C (enExample)
GR (1) GR81629B (enExample)
IE (1) IE57736B1 (enExample)
IL (1) IL72188A (enExample)
NO (1) NO161220C (enExample)
PH (1) PH19413A (enExample)
PT (1) PT78775A (enExample)
YU (1) YU43576B (enExample)
ZA (1) ZA844437B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
CA1254557A (en) * 1984-02-15 1989-05-23 Michael C. Venuti (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4766126A (en) * 1986-01-10 1988-08-23 Daiichi Seiyaku Co., Ltd. Process for treatment of nephritis with imidazoquinazolines
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4761416A (en) * 1986-07-25 1988-08-02 Syntex (U.S.A.) Inc. N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Also Published As

Publication number Publication date
IE57736B1 (en) 1993-03-24
ES8603483A1 (es) 1985-12-16
EP0129258B1 (en) 1987-09-23
NO161220B (no) 1989-04-10
AU558124B2 (en) 1987-01-22
DK162999B (da) 1992-01-06
DK290084A (da) 1984-12-22
KR850000442A (ko) 1985-02-27
DK290084D0 (da) 1984-06-13
ES533609A0 (es) 1985-12-16
YU43576B (en) 1989-08-31
EP0129258A1 (en) 1984-12-27
FI77864C (fi) 1989-05-10
ZA844437B (en) 1985-01-30
FI77864B (fi) 1989-01-31
NO842502L (no) 1984-12-27
PT78775A (en) 1984-07-01
PH19413A (en) 1986-04-10
GR81629B (enExample) 1984-12-11
FI842532L (fi) 1984-12-22
IL72188A (en) 1987-03-31
US4596806A (en) 1986-06-24
KR910003153B1 (ko) 1991-05-20
NO161220C (no) 1989-07-19
IL72188A0 (en) 1984-10-31
ATE29884T1 (de) 1987-10-15
FI842532A0 (fi) 1984-06-21
IE841549L (en) 1984-12-21
YU107884A (en) 1986-10-31
JPS604186A (ja) 1985-01-10
AU2943284A (en) 1985-01-03
DK162999C (da) 1992-06-01
JPS635030B2 (enExample) 1988-02-01
CA1231946A (en) 1988-01-26

Similar Documents

Publication Publication Date Title
DE3684631D1 (de) Direkt gesteuerte drehmaschine.
FI852516A0 (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
NO852546L (no) Framgangsmaate for framstilling av multilegerings-komponenter.
FI862263L (fi) Modifierad polyolefin.
ES296385Y (es) Perno conico.
FI841273A0 (fi) Foerfarande foer frmastaellning av nya furo-(3,4-c)- pyridinderivater.
FI844279A0 (fi) Foerfarande foer framstaellning av nya 6-vinyl-furo-(3,4-c)-pyridinderivat.
FI844383L (fi) Foerfarande foer framstaellning av nya 7-karboximetoxi-furo-(3,4-c)-pyridinderivat.
AU558124B2 (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)- quinazolin-2-one
DE3771540D1 (de) Drehmaschine.
DE3769279D1 (de) Drehmaschine.
FI854425A0 (fi) Anordning foer uppvaermning av passagerarutrymmen eller liknande, speciellt i bussar.
FI853321L (fi) Centrifug foer torkning av foertorkat slam.
FI844900A0 (fi) Foerfarande foer framstaellning av 4,5,6,7-tetrahydrotiazolo/5,4-c/pyridinderivat.
FI853805L (fi) Anordning foer inmatning av koaguleringsmedel i slam i inloppskammare av en centrifug.
FI852961L (fi) Foerfarande foer framstaellning av alkylestrar av -(4-hydroxi-3,5-di-tert.butylfenyl)-propionsyra.
FI844034A7 (fi) Foerfarande foer framstaellning av nya 4-klor-furo-(3,4-c)-pyridinderivat.
FI841336A7 (fi) Foerfarande foer framstaellning av symmetriska 1,4-dihydropyridin-dikarboxyl-syraestrar.
FI853287A0 (fi) Nytt foerfarande foer framstaellning av 6-substituerad-furo-(3,4-c)-pyridinderivat.
FI880733A0 (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
FI890065A0 (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.
FI880150A0 (fi) Anordning foer toemning av en saedesbehaollare i en skoerdetroeska.
FI893331A7 (fi) Foerfarande foer framstaellning av pyridylsubstituerade imidazo(2,1-b) tiazoler.
ES272251Y (es) Disposicion perfeccionada del bombillo de una cerradura.
FI861989L (fi) Amfibiefordon.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee